Dublin City University, Dublin, Ireland
Department of Oncology, University of Oxford, Oxford, UK.
BMJ Evid Based Med. 2022 Dec;27(6):319-323. doi: 10.1136/bmjebm-2021-111773. Epub 2021 Dec 21.
Vaccination is a life-saving endeavour, yet risk and uncertainty are unavoidable in science and medicine. Vaccination remains contentious in the public mind, and vaccine hesitancy is a serious public health issue. This has recently been reignited in the discussion over potential side effects of COVID-19 vaccines, and the decision by several countries to suspend measures such as the AstraZeneca vaccine. In these instances, the precautionary principle has often been invoked as a rationale, yet such heuristics do not adequately weigh potential harms against real benefits. How we analyse, communicate and react to potential harms is absolutely paramount to ensure the best decisions and outcomes for societal health, and maintaining public confidence. While balancing benefits and risks is an essential undertaking, it cannot be achieved without due consideration of several other pertinent factors, especially in the context of vaccination, where misguided or exaggerated fears have in the past imperilled public health. While well meaning, over reactions to potential hazards of vaccination and other health interventions can have unintended consequences, and cause lingering damage to public trust. In this analysis, we explore the challenges of assessing risk and benefit, and the limitations of the precautionary principle in these endeavours. When risk is unclear, cautious vigilance might be a more pragmatic and useful policy than reactionary suspensions.
疫苗接种是一项拯救生命的努力,但风险和不确定性在科学和医学中是不可避免的。疫苗接种在公众心目中仍然存在争议,疫苗犹豫是一个严重的公共卫生问题。最近,在讨论 COVID-19 疫苗的潜在副作用以及一些国家决定暂停阿斯利康疫苗等措施时,再次引发了这一问题。在这些情况下,预防原则经常被援引为一种理由,但这种启发式方法不能充分权衡潜在危害与实际收益。我们如何分析、沟通和应对潜在危害,对于确保社会健康的最佳决策和结果以及维护公众信心至关重要。虽然平衡收益和风险是一项基本任务,但如果不充分考虑其他几个相关因素,就无法实现这一目标,特别是在疫苗接种方面,过去错误或夸大的恐惧已经危及公共卫生。虽然用意良好,但对疫苗接种和其他健康干预措施的潜在危害的过度反应可能会产生意想不到的后果,并对公众信任造成持久的损害。在这项分析中,我们探讨了评估风险和收益的挑战,以及预防原则在这些努力中的局限性。当风险不明确时,谨慎警惕可能比反应性暂停更具务实性和有用性。